Story perspectives

Survivors Share Hope: Clinical Trials Beat Triple-Negative Breast Cancer

10/27/2025

50 7

Summary

Story summary

In November 2024, Marcela Tinka's tumor disappeared after ten chemotherapy sessions and immunotherapy at Ridley-Tree Cancer Center in a clinical trial.
Marcela Tinka was diagnosed with triple-negative breast cancer, which affects 10–15% of cases.
Latrivia Carter, diagnosed with stage 2 triple-negative breast cancer, chose a clinical trial for personalized treatment and has been cancer-free for over three years.
Both women emphasize clinical trials and early detection in cancer care.

1 of 1

Story summary

In November 2024, Marcela Tinka's tumor disappeared after ten chemotherapy sessions and immunotherapy at Ridley-Tree Cancer Center in a clinical trial.
Marcela Tinka was diagnosed with triple-negative breast cancer, which affects 10–15% of cases.
Latrivia Carter, diagnosed with stage 2 triple-negative breast cancer, chose a clinical trial for personalized treatment and has been cancer-free for over three years.
Both women emphasize clinical trials and early detection in cancer care.